A unique blood test for breast cancer early detection

A unique blood test for breast cancer early detection

A revolutionary blood test for breast cancer early detection

Breast cancer is the most common cancer, affecting 1 in 8 women worldwide, and is the leading cause of cancer-related death among women. Globally, 2.3 million women are diagnosed each year, and over 685,000 die from the disease — equivalent to nearly 2,000 deaths every day.

1 out of 8 women develop breast cancer and a third of them will die of it

When detected early, breast cancer can be cured in up to 98% of cases. However, when diagnosed at a late stage, the cure rate drops to just one-third of patients. While
mammography has demonstrated live-saving benefits, it also has inherent
limitations — highlighting the urgent need for innovative detection methods

Earyl breast cancer detection save lives

To meet this critical need, XEMPERIA has developed a blood test for breast cancer detection that harnesses the body’s natural immune response to tumors. The test uses a PCR-based platform to identify cancer-associated biomarkers, which are then analyzed by an algorithm to determine the presence or absence of breast cancer

2000 women die of brest cancer every day:
XEMPERIA’s blood test could save 98 % of them

Our test is unique in its conception, performance and convenience:

● Based on solid science

● It is 99% sensitive and >95% accurate (based on our GENOA study)

● Convenient for patients and doctors — simple blood draw, rapid results

● No radiation exposure, independent of tissue morphology

Our technology is intellectually protected

XEMPERIA’s test is designed to serve as the primary screening tool for breast cancer in women aged 35 to 75. It integrates seamlessly into existing clinical workflows and screening protocols.

Negative results will prompt annual follow-up testing, while positive results will lead to further evaluation using imaging techniques such as mammography, MRI, or ultrasound — and, if necessary, biopsy and histological analysis.

With its uniquely high sensitivity and accuracy, XEMPERIA’s blood test is redefining the future of breast cancer screening, enabling earlier and more effective detection that saves lives.

XEMPERIA’s blood test — offering 99% sensitivity and over 95% accuracy — is shaping the future of breast cancer screening, saving lives with earlier, better detection.

For more information download our brochure HERE

Interested in knowing more?